• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

释放一氧化氮的纳米颗粒作为改善当前甲癣治疗方法的一种策略。

Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments.

作者信息

Costa-Orlandi Caroline B, Mordorski Breanne, Baltazar Ludmila M, Mendes-Giannini Maria José S, Friedman Joel M, Nosanchuk Joshua D, Friedman Adam J

出版信息

J Drugs Dermatol. 2018 Jul 1;17(7):717-720.

PMID:30005092
Abstract

Topical antimicrobials are the ideal mode of onychomycosis treatment for efficient drug delivery and avoidance of sytemic effects associated with oral medications. However, high treatment costs, tissue penetration limitations, and low cure rates have continued to pose major challenges. To capitalize on the progress made by topical efinaconazole solution, efinaconazole was combined with inexpensive, previously-characterized nitric oxide releasing nanoparticles (NO-np), which have been shown to offer sustained nitric oxide release over time and enhanced barrier penetration, while exerting broad spectrum antimicrobial and immunomodulating properties. NO-np were combined with efinaconazole in varying concentrations and applied against reference strains of Trichophyton rubrum using a checkerboard method. Results demonstrated synergism of NO-np+efinaconazole against T. rubrum, which is noteworthy given the barriers present in the topical treatment of onychomycosis, and the multiple potential benefits offered by NO-np. Overall, this study illustrates the untapped potential of nanotechnology in the treatment of disorders of the skin, hair, and nails where drug delivery remains a challenge. J Drugs Dermatol. 2018;17(7):717-720.

摘要

局部用抗菌药物是治疗甲癣的理想方式,可实现高效给药并避免口服药物相关的全身效应。然而,高治疗成本、组织渗透限制和低治愈率一直是主要挑战。为利用局部用艾氟康唑溶液取得的进展,将艾氟康唑与廉价的、先前已表征的一氧化氮释放纳米颗粒(NO-np)相结合,这些纳米颗粒已被证明可随时间持续释放一氧化氮并增强屏障穿透能力,同时具有广谱抗菌和免疫调节特性。将不同浓度的NO-np与艾氟康唑混合,并使用棋盘法对红色毛癣菌参考菌株进行应用测试。结果表明,NO-np+艾氟康唑对红色毛癣菌具有协同作用,鉴于甲癣局部治疗存在的障碍以及NO-np提供的多种潜在益处,这一点值得关注。总体而言,本研究说明了纳米技术在治疗皮肤、毛发和指甲疾病方面尚未开发的潜力,在这些疾病中药物递送仍然是一个挑战。《皮肤药物学杂志》。2018年;17(7):717 - 720。

相似文献

1
Nitric Oxide Releasing Nanoparticles as a Strategy to Improve Current Onychomycosis Treatments.释放一氧化氮的纳米颗粒作为改善当前甲癣治疗方法的一种策略。
J Drugs Dermatol. 2018 Jul 1;17(7):717-720.
2
Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.艾氟康唑经指甲给药:其在甲癣患者指甲中的沉积及在人指甲中的体外杀菌活性。
J Drugs Dermatol. 2014 Nov;13(11):1388-92.
3
The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.艾氟康唑对角蛋白的低亲和力有助于其在局部甲真菌病治疗中的指甲穿透性和杀菌活性。
Antimicrob Agents Chemother. 2014 Jul;58(7):3837-42. doi: 10.1128/AAC.00111-14. Epub 2014 Apr 21.
4
In vitro and in vivo assessment of dermatophyte acquired resistance to efinaconazole, a novel triazole antifungal.新型三唑类抗真菌药艾氟康唑对皮肤癣菌获得性耐药的体外和体内评估
Antimicrob Agents Chemother. 2014 Aug;58(8):4920-2. doi: 10.1128/AAC.02703-13. Epub 2014 May 27.
5
Preparation and evaluation of a highly skin- and nail-permeable efinaconazole topical formulation for enhanced treatment of onychomycosis.制备并评价一种高透皮和透甲的依非康唑局部用制剂,以增强治疗甲真菌病的效果。
Drug Deliv. 2019 Dec;26(1):1167-1177. doi: 10.1080/10717544.2019.1687612.
6
Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.在含角蛋白介质中利用指甲渗透性和抗真菌活性确定的疗效系数,有助于预测外用药物治疗甲真菌病的临床疗效。
PLoS One. 2016 Jul 21;11(7):e0159661. doi: 10.1371/journal.pone.0159661. eCollection 2016.
7
How effective is efinaconazole in the management of onychomycosis?艾氟康唑治疗甲癣的效果如何?
Expert Opin Pharmacother. 2016;17(4):611-8. doi: 10.1517/14656566.2016.1146687. Epub 2016 Feb 15.
8
Nitric Oxide-Releasing Nanoparticles Are Similar to Efinaconazole in Their Capacity to Eradicate Biofilms.一氧化氮释放纳米颗粒在消除生物膜方面的能力与依氟康唑相似。
Front Cell Infect Microbiol. 2021 Jul 15;11:684150. doi: 10.3389/fcimb.2021.684150. eCollection 2021.
9
Topical treatment of onychomycosis with efinaconazole solution 10%.使用10%艾氟康唑溶液局部治疗甲癣。
Cutis. 2013 Jun;91(6):305-7.
10
Evaluation of drug susceptibility test for Efinaconazole compared with conventional antifungal agents.棘白菌素类药物敏感性试验与传统抗真菌药物的比较评估。
Mycoses. 2019 Mar;62(3):291-297. doi: 10.1111/myc.12870. Epub 2018 Dec 17.

引用本文的文献

1
Nitric Oxide-Releasing Microparticles: A Novel Treatment for Onychomycosis.释放一氧化氮的微粒:甲癣的一种新型治疗方法。
Mol Pharm. 2025 Sep 1;22(9):5567-5575. doi: 10.1021/acs.molpharmaceut.5c00613. Epub 2025 Aug 21.
2
Micro- and nanoparticles as platforms for the treatment of fungal infections: present and future perspectives.作为真菌感染治疗平台的微米和纳米颗粒:现状与未来展望
Future Microbiol. 2023 Nov;18(15):1007-1011. doi: 10.2217/fmb-2023-0079. Epub 2023 Sep 18.
3
Contemporary Techniques and Potential Transungual Drug Delivery Nanosystems for The Treatment of Onychomycosis.
当代技术与经皮给药纳米系统治疗甲真菌病的潜在研究进展。
AAPS PharmSciTech. 2023 Jul 8;24(6):150. doi: 10.1208/s12249-023-02603-x.
4
Nitric Oxide-Releasing Nanoparticles Are Similar to Efinaconazole in Their Capacity to Eradicate Biofilms.一氧化氮释放纳米颗粒在消除生物膜方面的能力与依氟康唑相似。
Front Cell Infect Microbiol. 2021 Jul 15;11:684150. doi: 10.3389/fcimb.2021.684150. eCollection 2021.
5
Synthetic, Natural, and Semisynthetic Polymer Carriers for Controlled Nitric Oxide Release in Dermal Applications: A Review.用于皮肤应用中一氧化氮控释的合成、天然和半合成聚合物载体:综述
Polymers (Basel). 2021 Feb 28;13(5):760. doi: 10.3390/polym13050760.
6
Onychomycosis: An Updated Review.甲癣:最新综述
Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):32-45. doi: 10.2174/1872213X13666191026090713.